Bright Brothers Past Earnings Performance
Past criteria checks 2/6
Bright Brothers's earnings have been declining at an average annual rate of -21.2%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 4.6% per year. Bright Brothers's return on equity is 6%, and it has net margins of 1.5%.
Key information
-21.2%
Earnings growth rate
-21.2%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 4.6% |
| Return on equity | 6.0% |
| Net Margin | 1.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bright Brothers makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,926 | 44 | 285 | 0 |
| 30 Jun 24 | 2,624 | -11 | 261 | 0 |
| 31 Mar 24 | 2,447 | -48 | 280 | 0 |
| 31 Dec 23 | 2,265 | -56 | 272 | 0 |
| 30 Sep 23 | 2,132 | -66 | 263 | 0 |
| 30 Jun 23 | 2,076 | -53 | 237 | 0 |
| 31 Mar 23 | 2,067 | -38 | 247 | 0 |
| 31 Dec 22 | 2,212 | -21 | 241 | 0 |
| 30 Sep 22 | 2,345 | 7 | 236 | 0 |
| 30 Jun 22 | 2,441 | 319 | 223 | 0 |
| 31 Mar 22 | 2,303 | 320 | 219 | 0 |
| 31 Dec 21 | 2,462 | 348 | 201 | 0 |
| 30 Sep 21 | 2,486 | 362 | 197 | 0 |
| 30 Jun 21 | 2,363 | 79 | 188 | 0 |
| 31 Mar 21 | 2,023 | 57 | 184 | 0 |
| 31 Dec 20 | 1,703 | 13 | 179 | 0 |
| 30 Sep 20 | 1,630 | 2 | 165 | 0 |
| 30 Jun 20 | 1,731 | -1 | 174 | 0 |
| 31 Mar 20 | 2,179 | 35 | 191 | 0 |
| 31 Dec 19 | 2,258 | 55 | 185 | 0 |
| 30 Sep 19 | 2,299 | 51 | 181 | 0 |
| 30 Jun 19 | 2,346 | 46 | 179 | 0 |
| 31 Mar 19 | 2,308 | 20 | 194 | 0 |
| 31 Dec 18 | 2,271 | 13 | 179 | 0 |
| 30 Sep 18 | 2,189 | 10 | 175 | 0 |
| 30 Jun 18 | 2,188 | 3 | 165 | 0 |
| 31 Mar 18 | 2,144 | 12 | 162 | 0 |
| 31 Dec 17 | 2,047 | 9 | 153 | 0 |
| 30 Sep 17 | 2,018 | -2 | 151 | 0 |
| 30 Jun 17 | 1,961 | -3 | 146 | 0 |
| 31 Mar 17 | 1,835 | -3 | 141 | 0 |
| 31 Dec 16 | 1,728 | -3 | 135 | 0 |
| 30 Sep 16 | 1,641 | -47 | 132 | 0 |
| 30 Jun 16 | 1,579 | -53 | 131 | 0 |
| 31 Mar 16 | 1,544 | -59 | 131 | 0 |
| 31 Dec 15 | 1,520 | -65 | 198 | 0 |
| 30 Sep 15 | 1,579 | -21 | 198 | 0 |
| 30 Jun 15 | 1,598 | -16 | 381 | 0 |
| 31 Mar 15 | 1,624 | -14 | 121 | 0 |
| 31 Dec 14 | 1,626 | -4 | 221 | 0 |
| 30 Sep 14 | 1,591 | 23 | 203 | 0 |
| 30 Jun 14 | 1,531 | 31 | 356 | 0 |
| 31 Mar 14 | 1,498 | 26 | 178 | 0 |
| 31 Dec 13 | 1,432 | 16 | 175 | 0 |
Quality Earnings: 526731 has high quality earnings.
Growing Profit Margin: 526731 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 526731's earnings have declined by 21.2% per year over the past 5 years.
Accelerating Growth: 526731 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 526731 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (8%).
Return on Equity
High ROE: 526731's Return on Equity (6%) is considered low.